Title:
新規な化合物
Document Type and Number:
Japanese Patent JP2020536103
Kind Code:
A
Abstract:
以下の式：(式中、q、r、s、A、B、C、RA1、RA2、RB1、RB2、RC1、RC2、R3、R4、R5、R6、R14、R15、R16、R17、Rx、及びRyは、本明細書中で定義されるとおりである)を有する化合物又はその互変異性体又はその塩、特に薬学的に許容される塩が開示される。【選択図】 なし
Inventors:
Fosvenner, David Tea.
Grayville, Todd El.
Kang, Jienshin
King, Brian W.
Ran, Yun Feng
Lastarr, Lara Kathryn
Mahajan, Mukeshke.
Mailman, John F.
Morales-Ramos, Angel Eye.
Pesiridis, George Scott
La Manduur, Josie M.
Romano, Joseph Jay.
Romeril, Stuart Paul
Schultz, Mark Jay.
Jou, Huician
Chu, Junya
Grayville, Todd El.
Kang, Jienshin
King, Brian W.
Ran, Yun Feng
Lastarr, Lara Kathryn
Mahajan, Mukeshke.
Mailman, John F.
Morales-Ramos, Angel Eye.
Pesiridis, George Scott
La Manduur, Josie M.
Romano, Joseph Jay.
Romeril, Stuart Paul
Schultz, Mark Jay.
Jou, Huician
Chu, Junya
Application Number:
JP2020519371A
Publication Date:
December 10, 2020
Filing Date:
October 04, 2018
Export Citation:
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
International Classes:
C07D403/14; A61K31/4184; A61K31/454; A61K31/5377; A61P3/10; A61P9/00; A61P9/04; A61P9/12; A61P11/00; A61P11/06; A61P13/12; A61P17/00; A61P17/06; A61P19/02; A61P21/00; A61P25/00; A61P25/14; A61P25/16; A61P25/28; A61P29/00; A61P37/02; A61P43/00; C07D405/14
Domestic Patent References:
| JP6746712B2 | 2020-08-26 | |||
| JP6861307B2 | 2021-04-21 | |||
| JP7119158B2 | 2022-08-16 |
Foreign References:
| WO2015185565A1 | 2015-12-10 | |||
| WO2017049401A1 | 2017-03-30 |
Attorney, Agent or Firm:
Hiraki International Patent Office